Health Trials

HISTOLOGICAL RESULTS IN TRANSGENDER INDIVIDUALS ASSIGNED TO FEMALES AT BIRTH UNDERGOING GENDER AFFIRMATION SURGERY AND IN TESTOSTERONE THERAPY

ConditionsPregnancySmoking BehaviorTestosterone Replacement TherapyDrugsComorbidities and Coexisting ConditionsGynecological SurgeryTransgender MenGender Affirmation SurgeryHormone Replacement TherapyGynecological Disorders
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

The aim of this study is to report histological results of genital organs removed during gender affirmg surgery in transgender people assigned female at birth (AFAB), to increase the knowledge about the long-term effects of gender affirming hormone therapy with testosterone on these organs and to evaluate the incidence of benign and malign gynecological pathology in AFAB transgender people.

Eligibility criteria

Qualifiers

gender incongruence diagnosis

people assigned female at birth

age >18 years

gender affirming surgery with hysterectomy

Disqualifiers

previous gynecological surgery

previous gynecological disorder diagnosis

Trial design

Treatments tested in this trial

  • analysis of medical records

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

Source ClinicalTrials.gov